These findings clearly showed that the negative regulation of DRP1 by YY2 suppressed HCC tumor‐initiating capacity by disrupting CSC homeostasis and promoting CSC differentiation, thereby depleting the CSC pool. Here, YY2 is linked to hepatocellular carcinoma.